Skip to main content
CDC Website

Health Professionals

PrEPonDemand

Contact organization for eligibility

Free Services Available

  • Free HIV Test
  • Free Hepatitis C Test
  • Free STI Test

Payment and Low Cost Options

  • Insurance Accepted
  • Medicaid Accepted
  • No Fee
  • PrEP for uninsured

  • Condom Distribution
  • HIV Test Counseling
  • HIV/AIDS Prevention/Education
  • Hepatitis Prevention/Education
  • STI Prevention/Education

  • Adult Hepatitis B Vaccine
  • Doxy PEP
  • Family Planning
  • HIV/AIDS Medical Treatment
  • Hepatitis A Vaccine
  • Hepatitis B Treatment
  • Hepatitis C Treatment
  • Post-Exposure Prophylaxis (PEP)
  • Pre-Exposure Prophylaxis (PrEP)
  • STI Treatment

  • PrEP Navigation

Nova Patient Care

Contact organization for eligibility

Payment and Low Cost Options

  • Fee
  • Insurance Accepted
  • Medicaid Accepted
  • Sliding Scale

  • Chlamydia Test
  • Gonorrhea Test
  • Hepatitis A Test
  • Hepatitis B Test
  • Syphilis Test

  • HIV Test Counseling
  • Hepatitis Prevention/Education
  • STI Prevention/Education
  • TB Prevention/Education

  • Family Planning
  • HIV/AIDS Medical Treatment
  • Hepatitis A Vaccine
  • Hepatitis C Treatment
  • Medication Adherence Education and Counseling

  • Case Management

Nova Patient Care

Contact organization for eligibility

Payment and Low Cost Options

  • Fee
  • Insurance Accepted
  • Medicaid Accepted
  • Sliding Scale

  • Chlamydia Test
  • Gonorrhea Test
  • Hepatitis A Test
  • Hepatitis B Test
  • Hepatitis C Test
  • Herpes Test

  • HIV Test Counseling
  • HIV/AIDS Prevention/Education
  • Hepatitis Prevention/Education
  • STI Prevention/Education
  • TB Prevention/Education

  • Family Planning
  • HIV/AIDS Medical Treatment
  • Hepatitis A Vaccine
  • Hepatitis B Treatment
  • Hepatitis C Treatment
  • STI Treatment
  • TB Treatment

  • Case Management

Nova Patient Care

Contact organization for eligibility

Payment and Low Cost Options

  • Fee

  • Chlamydia Test
  • Gonorrhea Test
  • Hepatitis A Test
  • Hepatitis B Test
  • Hepatitis C Test
  • Herpes Test
  • Syphilis Test
  • TB Test

  • HIV Test Counseling
  • Hepatitis Prevention/Education
  • STI Prevention/Education

  • Adult Hepatitis B Vaccine
  • Family Planning
  • HIV/AIDS Medical Treatment
  • Hepatitis A Vaccine
  • Hepatitis B Treatment
  • Human Papillomavirus Vaccine (HPV)
  • Medication Adherence Education and Counseling
  • STI Treatment
  • TB Treatment

  • Case Management

Tuberculosis: A Disease Neglected, Misunderstood, but Deadly

This webinar session, Tuberculosis: A Disease Neglected, Misunderstood, but Deadly, provides a comprehensive overview of TB’s microbiology, pathophysiology, and current epidemiology, along with effective strategies for public health prevention and clinical management. Facilitated by Gavin Harris, MD (Emory University), the program features didactic instruction from Marcos C.

New TB Treatment Guidelines: A Clinician's Guide to the ATS/CDC/ERS/IDSA 2025 Update

his webinar session features a case-based discussion on the management of tuberculosis in alignment with the 2025 ATS/CDC/ERS/IDSA Clinical Practice Guidelines. Lahari Tumuluri, MD (Tulane University), will present two TB cases illustrating the application of these guidelines. Jussi Saukkonen, MD (Boston University), and Charles Daley, MD (National Jewish), will review the guideline development process, supporting evidence, and practical implications for treating drug-sensitive and drug-resistant TB, drawing on real-world clinical experience.

Latent Tuberculosis Infection LTBI and Community Providers

The webinar is to enhance community medical providers’ awareness of latent tuberculosis infection (LTBI). A brief overview of latent tuberculosis vs. active tuberculosis is given along with the most recent numbers of TB cases in NYS and CDC estimates of those with LTBI. It encourages community providers to assess their patients for TB risk factors, then test and treat them for LTBI as indicated.

Estimating herd immunity thresholds for hepatitis A: A 16-state analysis to inform vaccination strategies among people who inject drugs (PWID)

This fact sheet discusses how research from the University of California San Diego and published in Clinical Infectious Diseases, estimates the hepatitis A vaccination coverage needed to prevent outbreaks among people who inject drugs (PWID). Analyzing surveillance data from 16 states with recent hepatitis A outbreaks linked to PWID, the study found that vaccination coverage of at least 80% may be necessary to reliably achieve herd immunity—though some states, such as West Virginia, may require higher levels.

Dr. Patrick Sullivan on PrEP 2024 - Higher State-level PrEP Coverage is associated with Declines in HIV Diagnoses

This webinar features a presentation from the March 2024 Conference on Retroviruses and Opportunistic Infections (CROI), where Dr. Patrick Sullivan—AIDSVu Principal Scientist and Professor at Emory University—presented the oral abstract, “Association of State-Level PrEP Coverage and State-Level HIV Diagnoses, US, 2012–2021.” Using real-world data on PrEP coverage, Dr. Sullivan’s study found that states with a higher proportion of people with PrEP indications who were using PrEP experienced steeper declines in new HIV diagnoses over the past decade.